Fibromyalgia is a chronic widespread pain condition, and one old idea about it keeps returning: that the body’s serotonin pathway runs low. 5-HTP is the direct precursor of serotonin, so it was an obvious candidate to test. Two studies from the early 1990s, each in 50 patients, reported improvement in fibromyalgia symptoms [1][2], but no larger modern trial is cited here, and a 2018 Cochrane review of combination drug treatment found the evidence base for fibromyalgia combinations thin overall [3]. This page lays out what those studies measured, what the serotonin data show, and what is missing, including the safety questions anyone on antidepressants should raise with a prescriber.
Key Takeaways
- A double-blind, placebo-controlled study in 50 patients with primary fibromyalgia reported that all clinical parameters studied improved significantly with 5-HTP, with only mild and transient side effects [1].
- A 90-day open study in 50 patients, with no placebo group, found improvements in tender points, anxiety, pain, sleep and fatigue versus baseline, and side effects in 15 patients (30%) [2].
- A 2018 case-control study found lower plasma 5-HTP, serotonin and 5-HIAA in 35 women with fibromyalgia than in 12 healthy women, which is an association and not a cause [4].
- The published summary of the placebo-controlled study gives no dose or duration, and its authors said further controlled studies were required [1].
- 5-HTP is a serotonin precursor, and serotonin syndrome is among the safety issues reviewed for it, so anyone taking an antidepressant should ask a prescriber first [5].
The Serotonin Hypothesis in Fibromyalgia
Fibromyalgia is described as a musculoskeletal pain and fatigue disorder with diffuse myalgia, localized tenderness, lowered pain thresholds and nonrestorative sleep [6]. A 1998 review argued that evidence from multiple sources supports decreased flux through the serotonin pathway in people with fibromyalgia, and that supplying serotonin substrate through L-tryptophan or 5-HTP had been shown to improve depression, anxiety, insomnia and somatic pain in a variety of patient groups [6].
That is a hypothesis built on indirect evidence. It was also written as a review, not as a trial, and the review itself suggested measuring serum tryptophan and serotonin to identify people most likely to respond.
What Blood Measurements Show
A more recent case-control study measured plasma monoamine neurotransmitters in 35 women with fibromyalgia and 12 age-matched healthy women [4]. The women with fibromyalgia had higher norepinephrine and lower dopamine, serotonin, 5-HIAA (the main serotonin breakdown product) and 5-HTP, while epinephrine and N-acetylserotonin did not differ.
The authors concluded that the data show dysregulation of the catecholamine and indolamine pathway that may contribute to the physiopathology of fibromyalgia [4]. They also found that higher norepinephrine was associated with worse physical health status, and suggested norepinephrine could help in diagnosis.
The group sizes are small, and the study measured levels at one time point. Lower 5-HTP in a patient’s blood does not by itself show that taking 5-HTP would correct the problem.
The Double-Blind Study in 50 Patients
The controlled evidence comes from a 1990 double-blind, placebo-controlled study of 5-HTP in 50 patients with primary fibromyalgia syndrome [1]. The published summary states that all the clinical parameters studied were significantly improved by 5-HTP and that only mild and transient side effects were reported.
The published summary is brief. It does not name the individual outcomes, the dose, the duration or the size of the improvements, and it ends by saying further controlled studies are required to define the value of 5-HTP in primary fibromyalgia [1]. That is a candid statement from the authors, and no large replication appears among the studies cited here.
The 90-Day Open Study
A 1992 study followed 50 patients with primary fibromyalgia on 5-HTP for 90 days in an open design, which means there was no placebo group and patients knew they were receiving treatment [2]. Compared with baseline, the number of tender points, anxiety, pain intensity, quality of sleep and fatigue all improved significantly (P less than 0.001).
Overall, the patient and the investigator rated the condition as a good or fair clinical improvement in nearly 50% of patients. Fifteen patients (30%) reported side effects, one was withdrawn from treatment for that reason, and no laboratory abnormality was observed [2]. The authors concluded that 5-HTP is effective and keeps its efficacy over 90 days.
Because there was no control group, that conclusion goes beyond what the design can support. Fibromyalgia symptoms fluctuate, and an uncontrolled before-and-after comparison cannot separate a drug effect from expectation or natural variation. The stronger claim belongs to the placebo-controlled study, and even there the published summary is thin.
What Is Missing From the Record
Both 5-HTP studies are more than 30 years old, each enrolled 50 patients, and neither published summary mentions the diagnostic criteria used by current guidelines. A 2018 Cochrane review of combination drug therapy for fibromyalgia pain gives a sense of how the field looks now: 16 studies with 1,474 participants, no meta-analysis possible because of heterogeneity, and a conclusion that there are few large, high-quality trials [3]. One of the 16 studies combined a monoamine oxidase inhibitor with 5-HTP in 200 participants, but the review reported no adequate evidence for any comparison on its primary and secondary outcomes.
So the honest summary is that 5-HTP in fibromyalgia has a plausible mechanism, one small placebo-controlled study with a positive result, one uncontrolled study with a positive result, and no replication among the studies cited here. That is a reason to treat the question as open, not a reason to dismiss it or to rely on it.
Safety and Drug Interactions
5-HTP is converted to serotonin in the body [7], which is what makes it interesting for a serotonin-linked condition and also what makes the safety questions specific. A review of 5-HTP for depression devoted its safety discussion to eosinophilia myalgia syndrome and serotonin syndrome [5], and a separate review discusses toxic impurities that have occurred in tryptophan and 5-HTP preparations [7].
This matters for fibromyalgia in particular because the drug combinations tested for it include antidepressants. The Cochrane review lists combinations such as amitriptyline with fluoxetine, melatonin with an antidepressant, and pregabalin with duloxetine [3]. Anyone taking an antidepressant, an MAO inhibitor or any other medicine that acts on serotonin should not add 5-HTP without talking to the prescriber, because the serotonin-syndrome risk is a recognized safety issue for 5-HTP.
Quality is the other concern. The impurity review’s summary gives no figure for how common contamination is today, so it cannot be read as saying any given product is unsafe. It does mean that third-party testing and a clinician’s input are reasonable before use.
Bottom Line
The evidence for 5-HTP in fibromyalgia is two small studies from the early 1990s: a 50-patient double-blind placebo-controlled study that reported significant improvement in all clinical parameters, and a 50-patient open 90-day study that reported improvement against baseline, with side effects in 30% of patients. Blood data show lower 5-HTP and serotonin in women with fibromyalgia, but that is an association. The published summaries leave out dose and duration for the controlled study, and no modern replication is described. Because 5-HTP raises serotonin, serotonin syndrome is a recognized concern, and anyone on an antidepressant or other serotonergic medicine should speak to their prescriber before trying it.
Frequently Asked Questions
Does 5-HTP help fibromyalgia?
It is unproven. A 1990 double-blind study in 50 patients reported that all clinical parameters studied improved significantly with 5-HTP, and a 1992 open study in 50 patients reported improvement in pain, sleep and fatigue. The published summaries give limited detail, and no larger modern trial is described, so the question remains open.
Is it safe to take 5-HTP with antidepressants for fibromyalgia?
Do not combine them without talking to your prescriber. 5-HTP is converted to serotonin, and serotonin syndrome is one of the safety issues reviewed for it. Antidepressants such as amitriptyline, fluoxetine and duloxetine are among the drugs studied in fibromyalgia combinations, so the overlap is common.
What side effects were reported in the fibromyalgia studies?
The double-blind study reported only mild and transient side effects. In the 90-day open study, 15 of 50 patients (30%) reported side effects, one patient was withdrawn because of them, and no laboratory abnormality was observed. Neither published summary lists the specific side effects.
References
- Caruso I, et al. Double-blind study of 5-hydroxytryptophan versus placebo in the treatment of primary fibromyalgia syndrome. Journal of International Medical Research (1990). PMID 2193835
- Sarzi Puttini P, et al. Primary fibromyalgia syndrome and 5-hydroxy-L-tryptophan: a 90-day open study. Journal of International Medical Research (1992). PMID 1521674
- Thorpe J, et al. Combination pharmacotherapy for the treatment of fibromyalgia in adults. Cochrane Database of Systematic Reviews (2018). PMID 29457627
- Rus A, et al. Catecholamine and Indolamine Pathway: A Case-Control Study in Fibromyalgia. Biological Research for Nursing (2018). PMID 30009619
- Turner EH, et al. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics (2006). PMID 16023217
- Juhl JH. Fibromyalgia and the serotonin pathway. Alternative Medicine Review (1998). PMID 9802912
- Maffei ME. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. International Journal of Molecular Sciences (2020). PMID 33375373
These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.


